Persistence of Rous sarcoma virus in transformed non-permissive cells: characteristics of virus induction following Sendai virus-mediated fusion with permissive cells.
D000818:Animals; D001358:Avian Sarcoma Viruses / Q000187:drug effects / Q000276:immunology*; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002459:Cell Fusion; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D002477:Cells / Q000276:immunology*; D002478:Cells, Cultured; D002642:Chick Embryo; D002999:Clone Cells; D006224:Cricetinae; D003561:Cytarabine / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D004279:DNA, Viral / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D005347:Fibroblasts / Q000276:immunology; D007111:Immunity, Cellular; D007668:Kidney; D010222:Parainfluenza Virus 1, Human; D012367:RNA, Viral / Q000096:biosynthesis; D001357:Sarcoma, Avian / Q000276:immunology*; D013997:Time Factors; D014779:Virus Replication / Q000187:drug effects
D004279:DNA, Viral; D012367:RNA, Viral; D003561:Cytarabine; D003609:Dactinomycin; D001973:Bromodeoxyuridine